AHA: Pro-Vegetarian Diet Could Lower CVD Mortality Risk by 20%

Share this content:
AHA: Pro-Vegetarian Diet Could Lower CVD Mortality Risk by 20%
AHA: Pro-Vegetarian Diet Could Lower CVD Mortality Risk by 20%

FRIDAY, March 6, 2015 (HealthDay News) -- Eating a diet that is mostly plant-based can lower cardiovascular mortality by up to 20 percent, compared to eating a diet that is over 50 percent meat, dairy, eggs, and fish, according to a new study. The findings were scheduled for presentation Thursday at the American Heart Association's Epidemiology and Prevention/Lifestyle and Cardiometabolic Health 2015 Scientific Sessions, held from March 3 to 6 in Baltimore.

The findings are based on 451,256 adults aged 35 to 70 who took part in a European study on nutrition and cancer risk. At the outset, they gave detailed information on their diets and lifestyle. Over the next 13 years, 5,083 died from cardiovascular disease.

Camille Lassale, Ph.D., of the Imperial College London School of Public Health, and colleagues looked at the study participants' diet information and gave each person a score based on how "pro-vegetarian" their eating pattern was. Those whose diets were about 70 percent plant-based -- meaning whole grains, beans, vegetables, fruit and nuts -- had a relatively lower risk of dying from cardiovascular disease. In addition, the researchers found that people with a "high" score were 20 percent less likely to die of cardiovascular disease than those with the lowest scores.

Lassale told HealthDay that her team accounted for some other potential explanations, such as people's weight, exercise habits, and education levels. But it's still difficult to pinpoint these "semi-vegetarian" diets as the reason for the lower rates of cardiovascular disease mortality.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »